Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 3/20 | 0.34 |
| ▸ | NAAA | Q02083 | 1/20 | 0.34 |
| ▸ | ME2 | P23368 | 2/20 | 0.33 |
| ▸ | ME1 | P48163 | 2/20 | 0.33 |
| ▸ | ME3 | Q16798 | 2/20 | 0.33 |
| ▸ | MGLL | Q99685 | 2/20 | 0.33 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.33 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | SLC16A3 | O15427 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | TTR | P02766 | 1/20 | 0.33 |
| ▸ | ESR1 | P03372 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16644696 | 0.89 | FAAH (0.35) | FAAHNAAAME2ME1ME3 | |
| SCHEMBL18353698 | 0.89 | SMN1; SMN2 (0.39) | FAAHNAAAMEN1KMT2AALDH1A1 | |
| SCHEMBL18353838 | 0.89 | FAAH (0.33) | FAAH | |
| SCHEMBL18353839 | 0.89 | FAAH (0.33) | FAAH | |
| SCHEMBL18354237 | 0.89 | FAAH (0.35) | FAAHALDH1A1 | |
| SCHEMBL18354236 | 0.89 | FAAH (0.33) | FAAH | |
| SCHEMBL30150862 | 0.88 | FAAH (0.33) | FAAHNAAAME2ME1ME3 | |
| SCHEMBL28455474 | 0.83 | — | — | |
| SCHEMBL18353699 | 0.83 | NAAA (0.38) | FAAHNAAAMGLLTDP1 | |
| SCHEMBL13939342 | 0.81 | KMT2A (0.39) | MEN1KMT2AKDM4EALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060035279-A1 | Anti-GPE antibodies, their uses and assays for weakly immunogenic molecules | NEUREN PHARMACEUTICALS LTD. (NZ) | 2006-02-16 | — | — | US | claimed |
| US-20250367350-A1 | CROSSLINKED HYDROGEL COATED MEDICAL GRAFTS | COOK BIOTECH INCORPORATED (US) | 2025-12-04 | — | — | US | disclosed |
| US-20250345478-A1 | PHOTOCROSSLINKABLE SYNTHETIC POLYMERS | Cook Biotech Incoporated (US) | 2025-11-13 | — | — | US | disclosed |
| US-20250325727-A1 | PHOTOCURABLE ADHESIVES WITH FERULATED PECTIN | COOK BIOTECH INCORPORATED (US) | 2025-10-23 | — | — | US | disclosed |
| US-20250295834-A1 | SUBTISSUE IMPLANT MATERIAL | COOK BIOTECH INCORPORATED (US) | 2025-09-25 | — | — | US | disclosed |
| EP-3057621-B1 | POLYMERIC RADIATION-SOURCES | IP LIBERTY VISION CORP (US) | 2025-05-14 | — | — | EP | disclosed |
| EP-4547258-A1 | NANOPARTICLES AND TEMPLATE DIRECTED RIG-I AGONIST PRECURSOR COMPOSITIONS AND USES THEREOF FOR CANCER THERAPY | Transcode Therapeutics, Inc. (US) | 2025-05-07 | — | — | EP | disclosed |
| US-11957933-B2 | Polymeric radiation-sources | IP LIBERTY VISION CORPORATION (US) | 2024-04-16 | — | — | US | disclosed |
| US-20240042070-A1 | NANOPARTICLES AND TEMPLATE DIRECTED RIG-I AGONIST PRECURSOR COMPOSITIONS AND USES THEREOF FOR CANCER THERAPY | TRANSCODE THERAPEUTICS, INC. | 2024-02-08 | — | — | US | disclosed |
| WO-2024006362-A1 | NANOPARTICLES AND TEMPLATE DIRECTED RIG-I AGONIST PRECURSOR COMPOSITIONS AND USES THEREOF FOR CANCER THERAPY | TRANSCODE THERAPEUTICS, INC. (US) | 2024-01-04 | — | — | WO | disclosed |
| US-5928667-A | Drug delivery device and method for employing the same | UNIVERSITY OF MARYLAND (US) | 1999-07-27 | — | — | US | disclosed |
| US-5874238-A | A DNA MOLECULE ENCODING A MUTANT MAMMALIAN C-REACTIVE PROTEIN WHICH HAS AT LEAST ONE CYSTEINE DELETED OR REPLACED BY OTHER AMINO ACID, FOR BINDING AGGREGATED IMMUNOGLOBULIN AND IMMUNE COMPLEXES, TREATING INFECTIONS, ENDOTOXIC SHOCK, CANCER | IMMTECH INTERNATIONAL INC. (US) | 1999-02-23 | — | — | US | disclosed |
| US-5788959-A | Drug delivery device and method for employing the same | UNIVERSITY OF MARYLAND, BALTIMORE COUNTY (US) | 1998-08-04 | — | — | US | disclosed |
| WO-1996006624-A1 | A MUTANT PROTEIN AND METHODS AND MATERIALS FOR MAKING AND USING IT | IMMTECH INTERNATIONAL, INC. (US) | 1996-03-07 | — | — | WO | disclosed |
| WO-1993020107-A1 | RECOMBINANT ACTIVE FORMS OF ECEF, PROTEINS THAT ASSOCIATE THEREWITH, AND USES THEREOF | BRIGHAM AND WOMEN'S HOSPITAL (US) | 1993-10-14 | — | — | WO | disclosed |
| EP-0454367-A2 | Growth hormone releasing factor analogs | ELI LILLY AND COMPANY (US) | 1991-10-30 | — | — | EP | disclosed |
| EP-0194545-B1 | LABELLING OF OLIGONUCLEOTIDES | MOLECULAR DIAGNOSTICS, INC. (US) | 1989-12-06 | — | — | EP | disclosed |
| WO-1989002752-A1 | METHOD OF DIAGNOSING BLOOD CLOTS USING FIBRIN-BINDING PROTEINS | GENENTECH, INC. (US) | 1989-04-06 | — | — | WO | disclosed |
| US-4808520-A | HYBRIDIZING WITH NUCLEIC ACID, THEN WITH NUCLEOSIDE TRIPHOSPHATE IN PRESENCE OF ENZYME | MOLECULAR DIAGNOSTICS, INC. (US) | 1989-02-28 | — | — | US | disclosed |
| EP-0194545-A2 | Labelling of oligonucleotides | MOLECULAR DIAGNOSTICS, INC. (US) | 1986-09-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240042070-A1 | NANOPARTICLES AND TEMPLATE DIRECTED RIG-I AGONIST PRECURSOR COMPOSITIONS AND USES THEREOF FOR CANCER THERAPY | MICA, NTPCR, MTREX | FAAH 3807/4885NAAA 4099/4885ME2 4439/4885 |
| US-11957933-B2 | Polymeric radiation-sources | RAD54L, RAD18, RAD51 | FAAH 2817/4885NAAA 2530/4885ME2 3588/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.